{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T03:58:49Z","timestamp":1790135929261,"version":"4.0.1"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":409,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011898","name":"Marianne and Marcus Wallenberg Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011898","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Swedish Heart and Lung Foundation"},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","award":["2009-1039"],"award-info":[{"award-number":["2009-1039"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","award":["349-2006-23"],"award-info":[{"award-number":["349-2006-23"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","award":["IRC15-006"],"award-info":[{"award-number":["IRC15-006"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007687","name":"Swedish Medical Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007687","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Sk\u00e5ne Region Research Funds"},{"name":"Skane University Hospital Funds"},{"DOI":"10.13039\/501100003173","name":"Crafoord Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003173","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005753","name":"Royal Physiographic Society in Lund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005753","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Bundy Academy foundation at Lund University"},{"name":"Lund University Diabetes Center"},{"name":"Ministry of Research, Innovation and Digitalization of Romania","award":["PNRR-C9\/I8-CF148"],"award-info":[{"award-number":["PNRR-C9\/I8-CF148"]}]},{"DOI":"10.13039\/501100003793","name":"Hj\u00e4rt-Lungfonden","doi-asserted-by":"publisher","award":["20200113"],"award-info":[{"award-number":["20200113"]}],"id":[{"id":"10.13039\/501100003793","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2020-02984"],"award-info":[{"award-number":["2020-02984"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011898","name":"Marcus och Amalia Wallenbergs minnesfond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011898","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003793","name":"Hj\u00e4rt-Lungfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003793","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2009\u20101039"],"award-info":[{"award-number":["2009\u20101039"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["349\u20102006\u201023"],"award-info":[{"award-number":["349\u20102006\u201023"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["IRC15\u2010006"],"award-info":[{"award-number":["IRC15\u2010006"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007687","name":"Svenska L\u00e4kares\u00e4llskapet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007687","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003173","name":"Crafoordska Stiftelsen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003173","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003793","name":"Hj\u00e4rt-Lungfonden","doi-asserted-by":"publisher","award":["20200113"],"award-info":[{"award-number":["20200113"]}],"id":[{"id":"10.13039\/501100003793","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2020\u201002984"],"award-info":[{"award-number":["2020\u201002984"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Carbohydrate antigen 125 (CA125), a mucin produced by serosal cells in response to mechanical and inflammatory stimuli, has emerged as an important biomarker to guide risk stratification in heart failure (HF). The prognostic value of CA125 in acute coronary syndrome (ACS) patients is less explored.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In a cohort of 524 ACS patients (73% males, mean age 67 \u00b1 12 years), we assessed the associations between CA125 and the risk for HF and death during a median follow-up period of 27.3 months for incident HF and 39.5 months for mortality. Plasma CA125 was measured within 24 h after admission in the entire cohort and after 6 weeks in a subgroup of 115 elderly patients (&amp;gt;75 years of age). We also assessed the relationships between baseline CA125 and echocardiographic parameters of cardiac structure and function at 1 year post-ACS in this subgroup.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Baseline CA125 was associated with incident HF in the entire cohort in a Cox proportional hazards model adjusted for age, sex, cardiovascular (CV) risk factors (diabetes, smoking, hypertension, previous HF, previous ACS and previous stroke), renal function and revascularization {hazard ratio [HR] 1.46 [95% confidence interval (CI) 1.10\u20131.93] per 1-standard deviation [SD] CA125 increase; P = 0.009}. In the detailed follow-up subgroup, elevated baseline CA125 predicted subsequent deterioration of left ventricular (LV) ejection fraction (LVEF), defined as a &amp;gt;5% absolute LVEF decrease in patients with LVEF \u2265 50% at discharge [odds ratio (OR) 3.31 (95% CI 1.15\u20139.54) per 1-SD baseline CA125 increase; P = 0.027]. We also found significant correlations between high baseline CA125 and larger LV volumes (LV end-diastolic volume index, Spearman's r = 0.329, P &amp;lt; 0.001; LV end-systolic volume index, r = 0.391, P &amp;lt; 0.001) and left atrial volume index (r = 0.320, P &amp;lt; 0.001) at 1 year post-ACS, indicative of adverse cardiac remodelling. Elevated baseline and follow-up CA125 were associated with increased mortality, independently of age and sex [HR 1.37 (95% CI 1.09\u20131.71), P = 0.006, per 1-SD baseline CA125; HR 1.98 (95% CI 1.06\u20133.67), P = 0.031, per increasing 6 week CA125 tertile]. The relationship between 6 week CA125 and incident mortality remained significant in the fully adjusted model [HR 2.23 (95% CI 1.15\u20134.35) per increasing CA125 tertile; P = 0.018].<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We report independent associations between elevated CA125, LV dysfunction, cardiac remodelling, incident HF and mortality post-ACS. Our results warrant further evaluation of CA125 as a potential biomarker for risk stratification and management of ACS patients, both at the time of the acute coronary event and during follow-up.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ehf2.15037","type":"journal-article","created":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T02:04:55Z","timestamp":1725242695000},"page":"4325-4334","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Elevated Carbohydrate Antigen 125 (CA125) is Associated with Incident Heart Failure and Mortality in Acute Coronary Syndrome"],"prefix":"10.1093","volume":"11","author":[{"given":"Troels","family":"Yndigegn","sequence":"first","affiliation":[{"name":"Department of Clinical Sciences Lund, Lund University , Lund ,","place":["Sweden"]},{"name":"Department of Cardiology, Sk\u00e5ne University Hospital Lund , Lund ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Gu","sequence":"additional","affiliation":[{"name":"Department of Translational Medicine, Lund University , Lund ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Grufman","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences Malm\u00f6, Lund University , Malm\u00f6 ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Erlinge","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences Lund, Lund University , Lund ,","place":["Sweden"]},{"name":"Department of Cardiology, Sk\u00e5ne University Hospital Lund , Lund ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arash","family":"Mokhtari","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences Lund, Lund University , Lund ,","place":["Sweden"]},{"name":"Department of Cardiology, Sk\u00e5ne University Hospital Lund , Lund ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf","family":"Ekelund","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Sk\u00e5ne University Hospital Lund , Lund ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Magnusson","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences Malm\u00f6, Lund University , Malm\u00f6 ,","place":["Sweden"]},{"name":"Department of Cardiology, Sk\u00e5ne University Hospital Malm\u00f6 , Malm\u00f6 ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Gustafsson","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences Malm\u00f6, Lund University , Malm\u00f6 ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Nilsson","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences Malm\u00f6, Lund University , Malm\u00f6 ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Goncalves","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences Malm\u00f6, Lund University , Malm\u00f6 ,","place":["Sweden"]},{"name":"Department of Cardiology, Sk\u00e5ne University Hospital Malm\u00f6 , Malm\u00f6 ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandru","family":"Schiopu","sequence":"additional","affiliation":[{"name":"Department of Translational Medicine, Lund University , Lund ,","place":["Sweden"]},{"name":"Department of Internal Medicine, Sk\u00e5ne University Hospital Lund , Lund ,","place":["Sweden"]},{"name":"Nicolae Simionescu Institute of Cellular Biology and Pathology , Bucharest ,","place":["Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,9,1]]},"reference":[{"key":"2026012113121995800_ehf215037-bib-0001","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1093\/eurheartj\/ehu505","article-title":"Cardiovascular risk in post-myocardial infarction patients: Nationwide real world data demonstrate the importance of a long-term perspective","volume":"36","author":"Jernberg","year":"2015","journal-title":"Eur Heart J"},{"key":"2026012113121995800_ehf215037-bib-0002","doi-asserted-by":"publisher","first-page":"3056","DOI":"10.1093\/eurheartj\/ehx515","article-title":"Improved outcomes in patients with ST-elevation myocardial infarction during the last 20 years are related to implementation of evidence-based treatments: Experiences from the SWEDEHEART registry 1995\u20132014","volume":"38","author":"Szummer","year":"2017","journal-title":"Eur Heart J"},{"key":"2026012113121995800_ehf215037-bib-0003","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1136\/hrt.2006.093476","article-title":"Carbohydrate antigen 125: An emerging prognostic risk factor in acute heart failure?","volume":"93","author":"Nunez","year":"2007","journal-title":"Heart"},{"key":"2026012113121995800_ehf215037-bib-0004","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ijcard.2009.04.030","article-title":"CA125 levels among patients with advanced heart failure: An emerging independent predictor for survival","volume":"145","author":"Turgut","year":"2010","journal-title":"Int J Cardiol"},{"key":"2026012113121995800_ehf215037-bib-0005","doi-asserted-by":"publisher","first-page":"864","DOI":"10.2459\/jcm.0000000000000073","article-title":"Insights into the clinical implications of carbohydrate antigen 125 as a biomarker of heart failure: A meta-analysis and systematic review of published studies","volume":"15","author":"Zhuang","year":"2014","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"2026012113121995800_ehf215037-bib-0006","doi-asserted-by":"publisher","first-page":"27371","DOI":"10.1074\/jbc.M103554200","article-title":"Molecular cloning of the CA125 ovarian cancer antigen: Identification as a new mucin, MUC16","volume":"276","author":"Yin","year":"2001","journal-title":"J Biol Chem"},{"key":"2026012113121995800_ehf215037-bib-0007","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/s0002-8703(99)70438-7","article-title":"CA 125 and its relation to cardiac function","volume":"137","author":"N\u00e4gele","year":"1999","journal-title":"Am Heart J"},{"key":"2026012113121995800_ehf215037-bib-0008","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1111\/j.1540-8175.2008.00737.x","article-title":"CA125 tumoral marker plasma levels relate to systolic and diastolic ventricular function and to the clinical status of patients with chronic heart failure","volume":"25","author":"Vizzardi","year":"2008","journal-title":"Echocardiography"},{"key":"2026012113121995800_ehf215037-bib-0009","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1016\/s0735-1097(03)00306-4","article-title":"Serum levels of carbohydrate antigen 125 in patients with chronic heart failure: Relation to clinical severity, hemodynamic and doppler echocardiographic abnormalities, and short-term prognosis","volume":"41","author":"D'Aloia","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"2026012113121995800_ehf215037-bib-0010","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.jchf.2016.07.013","article-title":"Carbohydrate antigen-125-guided therapy in acute heart failure: CHANCE-HF: A randomized study","volume":"4","author":"N\u00fa\u00f1ez","year":"2016","journal-title":"JACC Heart Fail"},{"key":"2026012113121995800_ehf215037-bib-0011","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1007\/bf02850138","article-title":"Evaluation of tumor markers CA-125 and CEA in acute myocardial infarction","volume":"23","author":"Yalta","year":"2006","journal-title":"Adv Ther"},{"key":"2026012113121995800_ehf215037-bib-0012","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1007\/s00059-014-4132-8","article-title":"Clinical and prognostic value of elevated CA125 levels in patients with coronary heart disease","volume":"40","author":"Rong","year":"2015","journal-title":"Herz"},{"key":"2026012113121995800_ehf215037-bib-0013","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1097\/MCA.0b013e32832467a1","article-title":"Carbohydrate antigen-125: Additional accuracy in identifying patients at risk of acute heart failure in acute coronary syndrome","volume":"20","author":"de Gennaro","year":"2009","journal-title":"Coron Artery Dis"},{"key":"2026012113121995800_ehf215037-bib-0014","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1093\/ehjacc\/zuab036","article-title":"Predicting outcome in acute myocardial infarction: An analysis investigating 175 circulating biomarkers","volume":"10","author":"Eggers","year":"2021","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"2026012113121995800_ehf215037-bib-0015","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1093\/eurheartj\/ehs184","article-title":"Third universal definition of myocardial infarction","volume":"33","author":"Thygesen","year":"2012","journal-title":"Eur Heart J"},{"key":"2026012113121995800_ehf215037-bib-0016","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1136\/hrt.2010.195768","article-title":"The Swedish web-system for enhancement and development of evidence-based care in heart disease evaluated according to recommended therapies (SWEDEHEART)","volume":"96","author":"Jernberg","year":"2010","journal-title":"Heart"},{"key":"2026012113121995800_ehf215037-bib-0017","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0095192","article-title":"Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability","volume":"9","author":"Assarsson","year":"2014","journal-title":"PLoS ONE"},{"key":"2026012113121995800_ehf215037-bib-0018","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: An update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"28","author":"Lang","year":"2015","journal-title":"J Am Soc Echocardiogr"},{"key":"2026012113121995800_ehf215037-bib-0019","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.echo.2003.12.004","article-title":"A practical approach to the echocardiographic evaluation of diastolic function","volume":"17","author":"Khouri","year":"2004","journal-title":"J Am Soc Echocardiogr"},{"key":"2026012113121995800_ehf215037-bib-0020","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.jacc.2007.05.019","article-title":"Echocardiography in heart failure: Applications, utility, and new horizons","volume":"50","author":"Kirkpatrick","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"2026012113121995800_ehf215037-bib-0021","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.1009691","article-title":"Prognostic impact of incident left ventricular systolic dysfunction after myocardial infarction","volume":"9","author":"Yoshioka","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"2026012113121995800_ehf215037-bib-0022","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1016\/s0002-9149(98)00123-3","article-title":"Changes in absolute and relative importance in the prognostic value of left ventricular systolic function and congestive heart failure after acute myocardial infarction. TRACE Study Group. Trandolapril cardiac evaluation","volume":"81","author":"Kober","year":"1998","journal-title":"Am J Cardiol"},{"key":"2026012113121995800_ehf215037-bib-0023","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/s0735-1097(99)00630-0","article-title":"Cardiac remodeling\u2014Concepts and clinical implications: A consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling","volume":"35","author":"Cohn","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"2026012113121995800_ehf215037-bib-0024","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.mehy.2012.05.028","article-title":"New mechanism of elevated CA125 in heart failure: The mechanical stress and inflammatory stimuli initiate CA125 synthesis","volume":"79","author":"Huang","year":"2012","journal-title":"Med Hypotheses"},{"key":"2026012113121995800_ehf215037-bib-0025","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1253\/jcj.57.489","article-title":"Usefulness of serum CA125 measurement for monitoring pericardial effusion","volume":"57","author":"Seo","year":"1993","journal-title":"Jpn Circ J"},{"key":"2026012113121995800_ehf215037-bib-0026","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1002\/ejhf.2077","article-title":"Antigen carbohydrate 125 as a biomarker in heart failure: A narrative review","volume":"23","author":"N\u00fa\u00f1ez","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"2026012113121995800_ehf215037-bib-0027","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1093\/eurjhf\/hfr033","article-title":"Tumour biomarkers in heart failure: Is there a role for CA-125?","volume":"13","author":"Yilmaz","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"2026012113121995800_ehf215037-bib-0028","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.ijcard.2010.04.081","article-title":"CA125 and immunoinflammatory activity in acute heart failure","volume":"145","author":"Minana","year":"2010","journal-title":"Int J Cardiol"},{"key":"2026012113121995800_ehf215037-bib-0029","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/s0008-6363(01)00434-5","article-title":"The inflammatory response in myocardial infarction","volume":"53","author":"Frangogiannis","year":"2002","journal-title":"Cardiovasc Res"},{"key":"2026012113121995800_ehf215037-bib-0030","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1136\/jcp.47.3.263","article-title":"CA125 secretion by peritoneal mesothelial cells","volume":"47","author":"Zeillemaker","year":"1994","journal-title":"J Clin Pathol"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/11\/6\/4325\/64517168\/eschf_11_6_4325.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/11\/6\/4325\/64517168\/eschf_11_6_4325.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T18:14:23Z","timestamp":1769019263000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/11\/6\/4325\/8269378"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,1]]},"references-count":30,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,9,1]]},"published-print":{"date-parts":[[2024,12,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ehf2.15037","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,12]]},"published":{"date-parts":[[2024,9,1]]},"assertion":[{"value":"2024-01-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-13","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}